James R. Tobin, Director at TransMedics Group, Inc. (TMDX), sold 97,032 shares at $29.94 ($2.9M) on 2022-05-04, disclosed to the SEC on 2022-05-06.
Open-market sale of $2.9M TMDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.94 | 48,516 | $1.5M | 50.0% |
| 2 | $29.94 | 48,516 | $1.5M | 50.0% |
| Total | $29.94 avg | 97,032 | $2.9M | 100% |
| Filing → |
| TMDX | SELL | 2024-05-03 | $3.0M | — | Filing → |
| TMDX | SELL | 2024-03-05 | $2.2M | — | Filing → |
| TMDX | SELL | 2023-11-29 | $701K | — | Filing → |